WO2013191699A1 - Cooling device for lipid-rich cell disruption - Google Patents

Cooling device for lipid-rich cell disruption Download PDF

Info

Publication number
WO2013191699A1
WO2013191699A1 PCT/US2012/043540 US2012043540W WO2013191699A1 WO 2013191699 A1 WO2013191699 A1 WO 2013191699A1 US 2012043540 W US2012043540 W US 2012043540W WO 2013191699 A1 WO2013191699 A1 WO 2013191699A1
Authority
WO
WIPO (PCT)
Prior art keywords
recited
subject
cooling
cooling surface
enclosure
Prior art date
Application number
PCT/US2012/043540
Other languages
French (fr)
Inventor
Liliana Paez
Original Assignee
Liliana Paez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liliana Paez filed Critical Liliana Paez
Priority to PCT/US2012/043540 priority Critical patent/WO2013191699A1/en
Priority to MX2012012158A priority patent/MX2012012158A/en
Publication of WO2013191699A1 publication Critical patent/WO2013191699A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/02Compresses or poultices for effecting heating or cooling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00132Setting operation time of a device
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0001Body part
    • A61F2007/0052Body part for treatment of skin or hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/007Heating or cooling appliances for medical or therapeutic treatment of the human body characterised by electric heating
    • A61F2007/0075Heating or cooling appliances for medical or therapeutic treatment of the human body characterised by electric heating using a Peltier element, e.g. near the spot to be heated or cooled
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0087Hand-held applicators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0093Heating or cooling appliances for medical or therapeutic treatment of the human body programmed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0095Heating or cooling appliances for medical or therapeutic treatment of the human body with a temperature indicator
    • A61F2007/0096Heating or cooling appliances for medical or therapeutic treatment of the human body with a temperature indicator with a thermometer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/02Compresses or poultices for effecting heating or cooling
    • A61F2007/0225Compresses or poultices for effecting heating or cooling connected to the body or a part thereof
    • A61F2007/0228Compresses or poultices for effecting heating or cooling connected to the body or a part thereof with belt or strap, e.g. with buckle

Definitions

  • the present invention relates to a handheld or mobile device used in connection with and for the disruption of subcutaneous, lipid-rich cells.
  • the device of the various embodiments of the present invention comprises an internal cooling assembly and an external cooling surface which is applied to the surface of a subject's skin, or in certain embodiments, an intermediate membrane disposed between the subject's skin and the cooling surface. Over the course of a predetermined amount of time, the cooling surface is structured to disrupt, cool or freeze the subcutaneous, lipid-rich cells, which are then ultimately removed by the natural processes of the body.
  • Obesity is a major problem, increasing the likelihood of developing numerous types of diseases, such as heart disease, diabetes, and high blood pressure. Aside from the negative health consequences, body fat also detracts from one's personal appearance by forming cellulite, which can manifest in the malformation of the surface of the skin.
  • the present invention described herein addresses the need for an apparatus that facilitates the ability to cool, freeze and/or otherwise disrupt lipid-rich cells without the need for large and cumbersome equipment.
  • the present invention is directed to a portable and handheld device for disrupting subcutaneous fat cells in a subject.
  • the device of the various embodiments of the present invention includes at least one cooling assembly, which in turn, comprises a corresponding cooling surface.
  • the cooling surface of the present invention when disposed in an operating position in contact with the surface of a subject's skin, is structured to decrease the temperature of subcutaneous fat cells within the subject and substantially adjacent the contact area of the subject's skin.
  • operational use of the device is obtained when the device is turned on or otherwise when the cooling surface is structured to maintain a predetermined temperature, and when the cooling surface is place in contact with the subject's skin or an intermediate membrane.
  • the device of the various embodiments further includes a control module with one or more control inputs.
  • the control inputs are controllably linked to the cooling assembly via internal control circuitry and corresponding software and/or hardware components.
  • the control inputs are structured to turn the device on or off, program the device to automatically turn off after a selected or predetermined time, or in order to select a temperature or operational mode.
  • each of the aforementioned components of the device is contained in a single portable enclosure or housing which is structured to be in the form of a handheld device.
  • the handheld device further comprises a securing assembly, preferably in the form of a belt or other like structure, which is capable of securing the device in a predetermined operating position against the subject's skin. Therefore, while the device of at least one embodiment is considered handheld by virtue of the small, compact configuration of the single enclosure, the securing assembly of one embodiment will securely hold the device in place without the need for the user to continuously hold the device against the subject's skin during operation.
  • the cooling assembly is disposed and configured within the enclosure such that the cooling surface thereof is exposed externally of the enclosure.
  • the cooling surface is exposed on the outside of the enclosure or housing in order to facilitate direct contact with the subject's skin or other operational contact area.
  • the present invention further comprises an intermediate membrane disposed between the subject's skin and the cooling surface.
  • the membrane which may be in the form of a glycerin membrane and/or a gelatinous substance, is structured to minimize or prevent disruption or damage to the outer skin layer of the operational contact area of the subject's skin .
  • Figure 1 illustrates a perspective view of a device as disclosed in accordance with at least one embodiment of the present invention.
  • Figure 2 illustrates a side view of the device of the present invention .
  • Figure 3 illustrates a side view of the device of the present invention .
  • Figure 4 illustrates a top view of the device of the present invention .
  • Figure 5 illustrates a bottom view of the device of the present invention showing the cooling surface.
  • Figure 6 illustrates the device of the present invention being placed on an area of skin on a subject.
  • Figure 7 illustrates the device of the present invention being placed on an area of skin on a subject with a belt attached.
  • Like reference numerals refer to like parts throughout the several views of the drawings .
  • the present invention is directed to a handheld apparatus or device that facilitates the ability to perform cooling of lipid-rich cells without the need for large and cumbersome equipment.
  • subcutaneous is used in reference to the tissues and cells lying beneath the dermis. Such layers include subcutaneous fat, which are composed of lipid-rich cells, or adipocytes. Lipid-rich cells may have a total intracellular lipid content of between about 20% to about 99%, which may be composed of about 20% to about 50% saturated triglycerides.
  • the present invention is directed to a device, generally indicated as 10, for disrupting and cooling subcutaneous fat cells in a subject.
  • the device 10 includes a cooling assembly 100, which comprises a cooling surface 110.
  • the cooling surface 110 is structured to decrease the temperature of subcutaneous fat cells when applied to the skin surface of the subject.
  • an operational contact area e.g., an area of the subject outer skin
  • the device is turned on or operating such that the cooling surface 110 is cooled
  • the subcutaneous fat cells adjacent the operational contact area will be cooled or disrupted to the point that the cells will thereafter be removed from the body via the body's natural occurrences.
  • the cells when exposed to cold temperatures from the device 10 of the present invention, the cells will crystallize, die and will not thereafter regenerate. The cells are then eliminated through the subject's liver via a process called apoptosis.
  • the operational contact area may be virtually any location on the subject, including, but certainly not limited to, the subject's abdominal region or any extremities including the arms and legs.
  • the cooling surface 110 of the various embodiments is structured for disposition directly against or in contact with the subject's skin at the operational contact area.
  • certain embodiments further include the use of an intermediate membrane and/or substance in order to protect the outer surface layer of the subject's skin.
  • the device 10 further includes a control module or internal control circuitry (not shown) with one or more external control inputs 210.
  • the control inputs 210 are controllably linked to the cooling assembly of the present invention in order to preprogram or preset the device 10 to be disposed in an "on" or operational mode for a certain desired amount of time.
  • each of the aforementioned components of the device 10 is contained in a single enclosure or housing 300 which, in certain embodiments, is structured to be in the form of a handheld device.
  • the device of at least one embodiment of the present invention comprises one or more handholds or handles 310 configured to be grasped by a subject or person treating an area on a subject.
  • the handholds 300 may also function as part of a securing assembly in that a belt, strap or other securing device may pass through the handhodls and secure the device to the user.
  • the device 10 of the various embodiments comprises a single, compact enclosure thereby allowing the device 10 to be used in leisure of a subject's home and by the subject, without the need for assistance or physician supervision.
  • the device 10 of the present invention is operational without the use of anesthesia and is non-invasive.
  • the cooling assembly 100 is disposed and configured within the enclosure 300 such that the cooling surface 110 is exposed externally of the enclosure 300.
  • the control module is also disposed within the enclosure 300 such that the control inputs 210 are externally exposed .
  • one of the control inputs 210 is an ON/OFF button 212.
  • some of the control inputs 210 are timing buttons 214 that control the length of time the cooling assembly 100 is in operation, thus providing an automatic turn-off once the requisite/desired length of time is attained.
  • the control module interacts with the cooling assembly 100 to automatically turn off the cooling assembly 100 once the requisite time is reached.
  • Such timing buttons 214 may provide timing increments, for example, of 5, 15, 30, or 60 minutes by pressing the proper button.
  • the buttons may also be illuminated in order to provide a visual indicator of the timing to be utilized.
  • the cooling assembly of the various embodiments of the present invention may employ a variety of cooling technologies known in the art, such as, but certainly not limited to, thermoelectric coolers, recirculating chilled fluid, phase change cryogenic devices, and vapor compression elements. Any current or future cooling technology will be useful in the present invention as long as it is capable of decreasing the temperature of subcutaneous fat cells when applied to the skin surface of the subject.
  • the entire cooling assembly 100 (aside from any electrical cord and power adaptor) is contained within the enclosure 300 such that the device 10 is self-contained, handheld and portable. Also, no high- voltage power supplies are necessary. Because of the self- contained aspect of the device 10, it may include a heat dissipating structure 120, such as a heatsink, as illustrated in FIGURE 4.
  • the cooling surface 110 may be a Peltier-type thermoelectric element.
  • the cooling surface 110 is capable of cooling subcutaneous, lipid-rich cells.
  • the cooling surface 110 is structured to maintain a temperature of between about -lOoC and OoC, and in preferred embodiment between -4oC and -2oC.
  • the cooling surface 110 may be in a planar (flat) configuration, as illustrated in FIGURE 5, or in a non-planar configuration (e.g., curved inwardly or outwardly) .
  • the various planar and non-planar configurations allow for ease of use in a variety of positions on the human body.
  • the cooling surface 110 may be constructed of a variety of materials that are capable of providing thermal conductivity great enough to provide for the rapid and continual cooling of subdermal tissue, as would be understood by those skilled in the art, and in order to facilitate the practice of the present invention in the intended manner. Exemplary materials include, but are certainly not limited to metal alloys, aluminum, graphite, ceramics, polymers, composite materials and the like.
  • the device 10 may be utilized in connection with an intermediate membrane M disposed between the cooling surface 110 and the subject's body region BR.
  • the intermediate membrane M is structured to protect the outer skin layer of the operational contact area of the subject's skin from damage or disruption resulting from the cooling temperatures of the cooling surface 110.
  • such membranes M may be composed of any substrate and/or solution that would be understood by those skilled in the art to effectively and efficiently provide a buffer between the subject's body region BR and the cooling surface 110 in order to prevent any skin surface damage by the cooling of the cooling surface 110.
  • a glycerin membrane may be utilized.
  • the membrane M of at least one embodiment comprises a cloth soaked in a glycerin solution or other solution.
  • the cloth may be prepackaged in the solution such that when removed from the packaging, the cloth or membrane M is precoated in the solution and ready for disposition between the subject's skin and the cooling surface 110.
  • the cloth or other structure may be mixed with the solution at the time of use and then disposed between the subject's skin and the cooling surface.
  • some membranes M of the various embodiments may be utilized multiple times, whereas other membranes M may be structured or intended for single use only.
  • the membrane M of a preferred embodiment is sized and configured to cover the entire cooling surface 110 of the device 10 such that the cooling surface 110 does not directly contact the subject's skin.
  • the membrane M may be approximately the size of an 8.5 x 11 sheet of paper, or otherwise big enough to cover the cooling surface 110, as just described.
  • the device 10 may also include a securing assembly or belt 400.
  • the belt or securing assembly 400 of certain embodiments is configured to engage the enclosure 300 or device 10 such that the device 10 can be securely and releasably positioned on a body portion of a subject.
  • the belt 400 may be configured such that it attaches to or engages with one or more of the handholds 310 of the device 10.
  • the belt 400 may either directly attach to one or more of the handholds 310 or run through one of the handholds 310, across the back surface of the device 10 and then through another handhold 310.
  • the securing assembly 400 may be removably secured or attached to the device 10, and in particular the housing 300 thereof. However, in other embodiments, the securing assembly 400 may be permanently secured or attached to one or more portions of the housing 300. Any securing assembly 400 or device structured to facilitate implementation of the present invention in the intended manner may be used, including, but certainly not limited to a VELCRO closure belt, or a belt, strap or other securing device comprising snaps, buttons, loops, etc. In any event, the securing assembly 400 of the various embodiments should not interfere with the cooling surface 110 and should therefore not be disposed across the cooling surface 110 or between the cooling surface 110 and the membrane M or operational contact area such as the subject's skin.
  • the device may additionally include one or more temperature sensors configured or disposed proximate to the cooling surface 110.
  • the temperature sensor (s) of such an embodiment may be configured to be flush with the cooling surface 110, below the cooling surface 110, or protrude from the cooling surface 110.
  • the temperature sensor (s) may be communicatively connected to the control module or internal circuitry for providing temperature readings of the cooling surface 110 and/or the surface of the subject's skin.
  • the temperature sensor (s) provide temperature readings to the control module in order for the control module to control the operation of the cooling assembly 100 in maintenance of the proper operating temperatures for effective and safe cooling of the subcutaneous lipid-rich cells.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Thermal Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)

Abstract

The present invention is directed to a device for cooling and disrupting subcutaneous fat cells in a subject. The device is composed of a cooling assembly with a cooling surface, a control module with control inputs, and a handheld, portable enclosure. The enclosure encompasses all components such that the device is compact and portable.

Description

Description
COOLING DEVICE FOR LIPID-RICH CELL DISRUPTION
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to a handheld or mobile device used in connection with and for the disruption of subcutaneous, lipid-rich cells. In particular, the device of the various embodiments of the present invention comprises an internal cooling assembly and an external cooling surface which is applied to the surface of a subject's skin, or in certain embodiments, an intermediate membrane disposed between the subject's skin and the cooling surface. Over the course of a predetermined amount of time, the cooling surface is structured to disrupt, cool or freeze the subcutaneous, lipid-rich cells, which are then ultimately removed by the natural processes of the body.
Description of the Related Art
Obesity is a major problem, increasing the likelihood of developing numerous types of diseases, such as heart disease, diabetes, and high blood pressure. Aside from the negative health consequences, body fat also detracts from one's personal appearance by forming cellulite, which can manifest in the malformation of the surface of the skin.
There are numerous surgical methods for removing excess body fat, such as liposuction and "tummy tucks"; however, such procedures are invasive surgical procedures and can have painful recovery times . Also, such procedures can sometimes prove fatal from complications from the procedures.
There are various "non-surgical" procedures for battling excessive body fat as well. These include weight-loss pills, exercise, and diet. However, some people do not find benefits in these procedures because of busy schedules, ineffective methods, and/or other health problems that prevent use of such procedures.
Others have recently described newer methods of reducing subcutaneous fat cells, which involve the controlled cooling of lipid-rich cells causing damage to the cells targeting them for natural removal processes by the body. During the cooling process, the epidermal and subdermal regions of the target area are cooled by a device. Lipid-rich cells are more sensitive to the lower temperatures compared to the surrounding cells causing selective damage to lipid-rich cells while sparing the surrounding non-lipid rich cells. Once the lipid-rich cells are damaged by the lower temperatures, they are ultimately removed by the natural processes of the body.
One of the drawbacks of the cooling method described is that it requires rather expensive, large and bulky equipment which significantly limits the availability of treatment. Thus, there is a significant need for less-expensive, portable devices that can provide a "cooling" effect to subcutaneous lipid-rich cells while allowing for treatments in a variety of locations and conditions, opening up the availability of such procedures to a larger population . Summary of the Invention
The present invention described herein addresses the need for an apparatus that facilitates the ability to cool, freeze and/or otherwise disrupt lipid-rich cells without the need for large and cumbersome equipment. As such, the present invention is directed to a portable and handheld device for disrupting subcutaneous fat cells in a subject.
In particular, the device of the various embodiments of the present invention includes at least one cooling assembly, which in turn, comprises a corresponding cooling surface. Specifically, when disposed in an operating position in contact with the surface of a subject's skin, the cooling surface of the present invention is structured to decrease the temperature of subcutaneous fat cells within the subject and substantially adjacent the contact area of the subject's skin. In particular, operational use of the device is obtained when the device is turned on or otherwise when the cooling surface is structured to maintain a predetermined temperature, and when the cooling surface is place in contact with the subject's skin or an intermediate membrane.
As will be described in further detail herein, the device of the various embodiments further includes a control module with one or more control inputs. The control inputs are controllably linked to the cooling assembly via internal control circuitry and corresponding software and/or hardware components. Specifically, the control inputs are structured to turn the device on or off, program the device to automatically turn off after a selected or predetermined time, or in order to select a temperature or operational mode.
Moreover, in order to facilitate ease of use, use of the device in a subject's home, and/or personal use of the present invention, in at least one embodiment, each of the aforementioned components of the device is contained in a single portable enclosure or housing which is structured to be in the form of a handheld device. In one embodiment, the handheld device further comprises a securing assembly, preferably in the form of a belt or other like structure, which is capable of securing the device in a predetermined operating position against the subject's skin. Therefore, while the device of at least one embodiment is considered handheld by virtue of the small, compact configuration of the single enclosure, the securing assembly of one embodiment will securely hold the device in place without the need for the user to continuously hold the device against the subject's skin during operation.
Furthermore, another aspect of the enclosure is that the cooling assembly is disposed and configured within the enclosure such that the cooling surface thereof is exposed externally of the enclosure. In other words, the cooling surface is exposed on the outside of the enclosure or housing in order to facilitate direct contact with the subject's skin or other operational contact area.
For example, in one embodiment, the present invention further comprises an intermediate membrane disposed between the subject's skin and the cooling surface. The membrane, which may be in the form of a glycerin membrane and/or a gelatinous substance, is structured to minimize or prevent disruption or damage to the outer skin layer of the operational contact area of the subject's skin .
These and other objects, features and advantages of the present invention will become clearer when the drawings as well as the detailed description are taken into consideration.
Brief Description of the Drawings
For a fuller understanding of the nature of the present invention, reference should be had to the following detailed description taken in connection with the accompanying drawings in which :
Figure 1 illustrates a perspective view of a device as disclosed in accordance with at least one embodiment of the present invention.
Figure 2 illustrates a side view of the device of the present invention .
Figure 3 illustrates a side view of the device of the present invention .
Figure 4 illustrates a top view of the device of the present invention .
Figure 5 illustrates a bottom view of the device of the present invention showing the cooling surface.
Figure 6 illustrates the device of the present invention being placed on an area of skin on a subject.
Figure 7 illustrates the device of the present invention being placed on an area of skin on a subject with a belt attached. Like reference numerals refer to like parts throughout the several views of the drawings .
Detailed Description of the Preferred Embodiment
As shown in the accompanying drawings, and with particular reference to FIGURE 1, the present invention is directed to a handheld apparatus or device that facilitates the ability to perform cooling of lipid-rich cells without the need for large and cumbersome equipment. Several aspects of the invention are described below, with reference to the drawings for illustrative purposes only. It should be understood that numerous specific details and relationships are set forth to provide a full understanding of the invention. One having ordinary skill in the relevant art, however, will readily recognize that the invention can be practiced without one or more of the specific details .
Unless otherwise defined, all terms of art, notations and other scientific terms or terminology used herein are intended to have the meanings commonly understood by those of skill in the art to which this invention pertains. In some cases, terms with commonly understood meanings are defined herein for clarity and/or for ready reference, and the inclusion of such definitions herein should not necessarily be construed to represent a substantial difference over what is generally understood in the art. It will be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the relevant art and/or as otherwise defined herein.
The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. As used herein, the indefinite articles "a", "an" and "the" should be understood to include plural reference unless the context clearly indicates otherwise.
The phrase "and/or," as used herein, should be understood to mean "either or both" of the elements so conjoined, i.e., elements that are conjunctively present in some cases and disjunctively present in other cases.
As used herein, "or" should be understood to have the same meaning as "and/or" as defined above. For example, when separating a listing of items, "and/or" or "or" shall be interpreted as being inclusive, i.e., the inclusion of at least one, but also including more than one, of a number of items, and, optionally, additional unlisted items. Only terms clearly indicated to the contrary, such as "only one of" or "exactly one of, " or, when used in the claims, "consisting of, " will refer to the inclusion of exactly one element of a number or list of elements. In general, the term "or" as used herein shall only be interpreted as indicating exclusive alternatives (i.e., "one or the other but not both") when preceded by terms of exclusivity, such as "either, " "one of, " "only one of," or "exactly one of."
As used herein, the terms "including", "includes", "having", "has", "with", or variants thereof, are intended to be inclusive similar to the term "comprising."
As used herein, the term "subcutaneous" is used in reference to the tissues and cells lying beneath the dermis. Such layers include subcutaneous fat, which are composed of lipid-rich cells, or adipocytes. Lipid-rich cells may have a total intracellular lipid content of between about 20% to about 99%, which may be composed of about 20% to about 50% saturated triglycerides.
With primary reference to FIGURES 1, 2 and 3, the present invention is directed to a device, generally indicated as 10, for disrupting and cooling subcutaneous fat cells in a subject. The device 10 includes a cooling assembly 100, which comprises a cooling surface 110. The cooling surface 110 is structured to decrease the temperature of subcutaneous fat cells when applied to the skin surface of the subject. In particular, as described herein, when the cooling surface 110 is disposed in contacting relation with an operational contact area, e.g., an area of the subject outer skin, and the device is turned on or operating such that the cooling surface 110 is cooled, as described herein, the subcutaneous fat cells adjacent the operational contact area will be cooled or disrupted to the point that the cells will thereafter be removed from the body via the body's natural occurrences. In particular, when exposed to cold temperatures from the device 10 of the present invention, the cells will crystallize, die and will not thereafter regenerate. The cells are then eliminated through the subject's liver via a process called apoptosis.
Further, the operational contact area may be virtually any location on the subject, including, but certainly not limited to, the subject's abdominal region or any extremities including the arms and legs. The cooling surface 110 of the various embodiments is structured for disposition directly against or in contact with the subject's skin at the operational contact area. However, as will be described below, certain embodiments further include the use of an intermediate membrane and/or substance in order to protect the outer surface layer of the subject's skin.
The device 10 further includes a control module or internal control circuitry (not shown) with one or more external control inputs 210. In particular, the control inputs 210 are controllably linked to the cooling assembly of the present invention in order to preprogram or preset the device 10 to be disposed in an "on" or operational mode for a certain desired amount of time.
Furthermore, each of the aforementioned components of the device 10 is contained in a single enclosure or housing 300 which, in certain embodiments, is structured to be in the form of a handheld device. Specifically, as shown in FIGURE 1, the device of at least one embodiment of the present invention comprises one or more handholds or handles 310 configured to be grasped by a subject or person treating an area on a subject. In other embodiments, described below, the handholds 300 may also function as part of a securing assembly in that a belt, strap or other securing device may pass through the handhodls and secure the device to the user.
Particularly, the device 10 of the various embodiments comprises a single, compact enclosure thereby allowing the device 10 to be used in leisure of a subject's home and by the subject, without the need for assistance or physician supervision. As can be appreciated by the description herein, the device 10 of the present invention is operational without the use of anesthesia and is non-invasive.
Another aspect of the enclosure 300 is that the cooling assembly 100 is disposed and configured within the enclosure 300 such that the cooling surface 110 is exposed externally of the enclosure 300. The control module is also disposed within the enclosure 300 such that the control inputs 210 are externally exposed . As shown in FIGURES 1 and 2, one of the control inputs 210 is an ON/OFF button 212. As shown in FIGURE 3, some of the control inputs 210 are timing buttons 214 that control the length of time the cooling assembly 100 is in operation, thus providing an automatic turn-off once the requisite/desired length of time is attained. The control module interacts with the cooling assembly 100 to automatically turn off the cooling assembly 100 once the requisite time is reached. Such timing buttons 214 may provide timing increments, for example, of 5, 15, 30, or 60 minutes by pressing the proper button. The buttons may also be illuminated in order to provide a visual indicator of the timing to be utilized.
The cooling assembly of the various embodiments of the present invention may employ a variety of cooling technologies known in the art, such as, but certainly not limited to, thermoelectric coolers, recirculating chilled fluid, phase change cryogenic devices, and vapor compression elements. Any current or future cooling technology will be useful in the present invention as long as it is capable of decreasing the temperature of subcutaneous fat cells when applied to the skin surface of the subject. Regardless of the technology utilized, the entire cooling assembly 100 (aside from any electrical cord and power adaptor) is contained within the enclosure 300 such that the device 10 is self-contained, handheld and portable. Also, no high- voltage power supplies are necessary. Because of the self- contained aspect of the device 10, it may include a heat dissipating structure 120, such as a heatsink, as illustrated in FIGURE 4. In some embodiments, the cooling surface 110 may be a Peltier-type thermoelectric element. The cooling surface 110 is capable of cooling subcutaneous, lipid-rich cells. In at least one embodiment of the present invention, the cooling surface 110 is structured to maintain a temperature of between about -lOoC and OoC, and in preferred embodiment between -4oC and -2oC.
The cooling surface 110 may be in a planar (flat) configuration, as illustrated in FIGURE 5, or in a non-planar configuration (e.g., curved inwardly or outwardly) . The various planar and non-planar configurations allow for ease of use in a variety of positions on the human body. Furthermore, the cooling surface 110 may be constructed of a variety of materials that are capable of providing thermal conductivity great enough to provide for the rapid and continual cooling of subdermal tissue, as would be understood by those skilled in the art, and in order to facilitate the practice of the present invention in the intended manner. Exemplary materials include, but are certainly not limited to metal alloys, aluminum, graphite, ceramics, polymers, composite materials and the like.
As illustrated in FIGURE 6, the device 10 may be utilized in connection with an intermediate membrane M disposed between the cooling surface 110 and the subject's body region BR. In particular, the intermediate membrane M is structured to protect the outer skin layer of the operational contact area of the subject's skin from damage or disruption resulting from the cooling temperatures of the cooling surface 110. Accordingly, such membranes M may be composed of any substrate and/or solution that would be understood by those skilled in the art to effectively and efficiently provide a buffer between the subject's body region BR and the cooling surface 110 in order to prevent any skin surface damage by the cooling of the cooling surface 110. In some embodiments, a glycerin membrane may be utilized. In particular, the membrane M of at least one embodiment comprises a cloth soaked in a glycerin solution or other solution. As an example, the cloth may be prepackaged in the solution such that when removed from the packaging, the cloth or membrane M is precoated in the solution and ready for disposition between the subject's skin and the cooling surface 110. In other embodiments, the cloth or other structure may be mixed with the solution at the time of use and then disposed between the subject's skin and the cooling surface. It should also be noted that some membranes M of the various embodiments may be utilized multiple times, whereas other membranes M may be structured or intended for single use only. The membrane M of a preferred embodiment is sized and configured to cover the entire cooling surface 110 of the device 10 such that the cooling surface 110 does not directly contact the subject's skin. As an example, the membrane M may be approximately the size of an 8.5 x 11 sheet of paper, or otherwise big enough to cover the cooling surface 110, as just described.
In some embodiments, as illustrated in FIGURE 7, the device 10 may also include a securing assembly or belt 400. Specifically, the belt or securing assembly 400 of certain embodiments is configured to engage the enclosure 300 or device 10 such that the device 10 can be securely and releasably positioned on a body portion of a subject. Moreover, as illustrated, the belt 400 may be configured such that it attaches to or engages with one or more of the handholds 310 of the device 10. The belt 400 may either directly attach to one or more of the handholds 310 or run through one of the handholds 310, across the back surface of the device 10 and then through another handhold 310. It should be noted that the securing assembly 400 may be removably secured or attached to the device 10, and in particular the housing 300 thereof. However, in other embodiments, the securing assembly 400 may be permanently secured or attached to one or more portions of the housing 300. Any securing assembly 400 or device structured to facilitate implementation of the present invention in the intended manner may be used, including, but certainly not limited to a VELCRO closure belt, or a belt, strap or other securing device comprising snaps, buttons, loops, etc. In any event, the securing assembly 400 of the various embodiments should not interfere with the cooling surface 110 and should therefore not be disposed across the cooling surface 110 or between the cooling surface 110 and the membrane M or operational contact area such as the subject's skin.
The device may additionally include one or more temperature sensors configured or disposed proximate to the cooling surface 110. In particular, the temperature sensor (s) of such an embodiment may be configured to be flush with the cooling surface 110, below the cooling surface 110, or protrude from the cooling surface 110. In any event, the temperature sensor (s) may be communicatively connected to the control module or internal circuitry for providing temperature readings of the cooling surface 110 and/or the surface of the subject's skin. The temperature sensor (s) provide temperature readings to the control module in order for the control module to control the operation of the cooling assembly 100 in maintenance of the proper operating temperatures for effective and safe cooling of the subcutaneous lipid-rich cells.
It is to be appreciated that the foregoing Detailed Description section, and not the Abstract section, is intended to be used to interpret the claims. The Abstract section may set forth one or more, but not all, exemplary embodiments of the present invention as contemplated by the inventor (s), and thus, is not intended to limit the present invention and the appended claims in any way.
The foregoing description of the specific embodiments should fully reveal the general nature of the invention so that others can, by applying knowledge within the skill of the art, readily modify and/or adapt for various applications such specific embodiments, without undue experimentation, without departing from the general concept of the present invention. Since many modifications, variations and changes in detail can be made to the described preferred embodiment of the invention, it is intended that all matters in the foregoing description and shown in the accompanying drawings be interpreted as illustrative and not in a limiting sense. Thus, the scope of the invention should be determined by the appended claims and their legal equivalents . Moreover, the breadth and scope of the present invention should not be limited by any of the above-described exemplary and illustrative embodiments, but should similarly be defined only in accordance with the following claims and their equivalents.
Now that the invention has been described,

Claims

Claims
1. A device for disrupting subcutaneous fat cells in a subject, said device comprising:
a cooling assembly, said cooling assembly comprising a cooling surface, wherein said cooling surface decreases the temperature of subcutaneous fat cells when applied to the skin surface of the subject;
a control module with control inputs, said control module controllably linked to said cooling assembly; and
a single portable enclosure structured to be in the form of a handheld device, wherein said cooling assembly is disposed within said enclosure such that said cooling surface is exposed externally of said enclosure, wherein said control module is disposed within said enclosure such that said control inputs are exposed externally of said enclosure.
2. The device as recited in claim 1 wherein said portable enclosure comprises two oppositely disposed handles configured to facilitate a subject's gripping engagement therewith.
3. The device as recited in claim 2 further comprising a securing assembly configured and attached to said enclosure such that the device can be securely positioned on a body portion of the subject.
4. The device as recited in claim 3 wherein said securing assembly is removably attached to said enclosure.
5. The device as recited in claim 4 wherein said securing assembly comprises a belt positioned through said two oppositely disposed handles.
6. The device as recited in claim 1 further comprising a temperature sensor configured proximate to said cooling surface, wherein said temperature sensor is communicatively connected to said control module for providing temperature readings of said cooling surface .
7. The device as recited in claim 1 further comprising an intermediate membrane disposed between said cooling surface and the skin surface of the subject during operation use of said device .
8. The device as recited in claim 7 wherein said membrane is sized larger than said cooling surface.
9. The device as recited in claim 7 wherein said intermediate membrane comprises a glycerin membrane.
10. The device as recited in claim 7 wherein said membrane comprises a cloth material presoaked in glycerin solution.
11. The device as recited in claim 1 wherein said cooling surface is maintained at a temperature between approximately -5oC and OoC during operational use of said device.
12. The device as recited in claim 11 wherein said cooling surface is maintained at a temperature between approximately -4oC and -2oC during operational use of said device.
13. A handheld, portable device for disrupting subcutaneous fat cells in a subject, said device comprising:
a portable enclosure,
a cooling assembly disposed at least partially within said portable enclosure, said cooling assembly comprising a cooling surface disposed external to said portable enclosure, said cooling surface being structured to decrease the temperature of subcutaneous fat cells when applied to the skin surface of the subject,
a control module disposed within said portable enclosure, said control module controllably linked with a plurality of control inputs ,
a securing assembly removably disposed in securing relation with a selected portion of the subject's body, wherein said cooling surface is disposed in a facing relation with the skin of the subject, and
an intermediate membrane disposed between said cooling surface and the skin surface of the subject.
14. The device as recited in claim 13 wherein said portable enclosure comprises at least one handle structured for gripping engagement by the subject.
15. The device as recited in claim 14 wherein said portable enclosure comprises two oppositely disposed handles .
16. The device as recited in claim 15 wherein said securing assembly comprises a belt removably disposed through said two oppositely disposed handles .
17. The device as recited in claim 13 wherein said cooling surface is maintained at a temperature between approximately -4oC and -2oC during operational use of said device.
18. The device as recited in claim 13 wherein said intermediate membrane comprises a glycerin infused membrane.
PCT/US2012/043540 2012-06-21 2012-06-21 Cooling device for lipid-rich cell disruption WO2013191699A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/US2012/043540 WO2013191699A1 (en) 2012-06-21 2012-06-21 Cooling device for lipid-rich cell disruption
MX2012012158A MX2012012158A (en) 2012-06-21 2012-06-21 Cooling device for lipid-rich cell disruption.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2012/043540 WO2013191699A1 (en) 2012-06-21 2012-06-21 Cooling device for lipid-rich cell disruption

Publications (1)

Publication Number Publication Date
WO2013191699A1 true WO2013191699A1 (en) 2013-12-27

Family

ID=49769151

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/043540 WO2013191699A1 (en) 2012-06-21 2012-06-21 Cooling device for lipid-rich cell disruption

Country Status (2)

Country Link
MX (1) MX2012012158A (en)
WO (1) WO2013191699A1 (en)

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10471269B1 (en) 2015-07-01 2019-11-12 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US10478633B2 (en) 2015-07-01 2019-11-19 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US10596386B2 (en) 2016-07-01 2020-03-24 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US10632321B2 (en) 2016-07-01 2020-04-28 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US10695576B2 (en) 2015-07-01 2020-06-30 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US10695575B1 (en) 2016-05-10 2020-06-30 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US10709894B2 (en) 2015-07-01 2020-07-14 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US10709895B2 (en) 2016-05-10 2020-07-14 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US10821295B1 (en) 2015-07-01 2020-11-03 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US11185690B2 (en) 2016-05-23 2021-11-30 BTL Healthcare Technologies, a.s. Systems and methods for tissue treatment
US11247039B2 (en) 2016-05-03 2022-02-15 Btl Healthcare Technologies A.S. Device including RF source of energy and vacuum system
US11247063B2 (en) 2019-04-11 2022-02-15 Btl Healthcare Technologies A.S. Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy
US11253718B2 (en) 2015-07-01 2022-02-22 Btl Healthcare Technologies A.S. High power time varying magnetic field therapy
US11253717B2 (en) 2015-10-29 2022-02-22 Btl Healthcare Technologies A.S. Aesthetic method of biological structure treatment by magnetic field
US11464993B2 (en) 2016-05-03 2022-10-11 Btl Healthcare Technologies A.S. Device including RF source of energy and vacuum system
US11491329B2 (en) 2020-05-04 2022-11-08 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient
US11491342B2 (en) 2015-07-01 2022-11-08 Btl Medical Solutions A.S. Magnetic stimulation methods and devices for therapeutic treatments
US11534619B2 (en) 2016-05-10 2022-12-27 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US11612758B2 (en) 2012-07-05 2023-03-28 Btl Medical Solutions A.S. Device for repetitive nerve stimulation in order to break down fat tissue means of inductive magnetic fields
US11633596B2 (en) 2020-05-04 2023-04-25 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient
US11896816B2 (en) 2021-11-03 2024-02-13 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030220674A1 (en) * 2002-03-15 2003-11-27 Anderson Richard Rox Methods and devices for selective disruption of fatty tissue by controlled cooling
US20070255362A1 (en) * 2006-04-28 2007-11-01 Juniper Medical, Inc. Cryoprotectant for use with a cooling device for improved cooling of subcutaneous lipid-rich cells
US20100280582A1 (en) * 2009-04-30 2010-11-04 Zeltiq Aesthetics, Inc. Device, system and method of removing heat from subcutaneous lipid-rich cells
US20110238050A1 (en) * 2010-01-25 2011-09-29 Zeltiq Aesthetics, Inc. Home-use applicators for non-invasively removing heat from subcutaneous lipid-rich cells via phase change coolants, and associates devices, systems and methods

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030220674A1 (en) * 2002-03-15 2003-11-27 Anderson Richard Rox Methods and devices for selective disruption of fatty tissue by controlled cooling
US20070255362A1 (en) * 2006-04-28 2007-11-01 Juniper Medical, Inc. Cryoprotectant for use with a cooling device for improved cooling of subcutaneous lipid-rich cells
US20100280582A1 (en) * 2009-04-30 2010-11-04 Zeltiq Aesthetics, Inc. Device, system and method of removing heat from subcutaneous lipid-rich cells
US20110238050A1 (en) * 2010-01-25 2011-09-29 Zeltiq Aesthetics, Inc. Home-use applicators for non-invasively removing heat from subcutaneous lipid-rich cells via phase change coolants, and associates devices, systems and methods

Cited By (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11612758B2 (en) 2012-07-05 2023-03-28 Btl Medical Solutions A.S. Device for repetitive nerve stimulation in order to break down fat tissue means of inductive magnetic fields
US10471269B1 (en) 2015-07-01 2019-11-12 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US10478633B2 (en) 2015-07-01 2019-11-19 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US11266850B2 (en) 2015-07-01 2022-03-08 Btl Healthcare Technologies A.S. High power time varying magnetic field therapy
US10695576B2 (en) 2015-07-01 2020-06-30 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US10709894B2 (en) 2015-07-01 2020-07-14 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US11491342B2 (en) 2015-07-01 2022-11-08 Btl Medical Solutions A.S. Magnetic stimulation methods and devices for therapeutic treatments
US10821295B1 (en) 2015-07-01 2020-11-03 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US11253718B2 (en) 2015-07-01 2022-02-22 Btl Healthcare Technologies A.S. High power time varying magnetic field therapy
US11253717B2 (en) 2015-10-29 2022-02-22 Btl Healthcare Technologies A.S. Aesthetic method of biological structure treatment by magnetic field
US11602629B2 (en) 2016-05-03 2023-03-14 Btl Healthcare Technologies A.S. Systems and methods for treatment of a patient including rf and electrical energy
US11247039B2 (en) 2016-05-03 2022-02-15 Btl Healthcare Technologies A.S. Device including RF source of energy and vacuum system
US11464993B2 (en) 2016-05-03 2022-10-11 Btl Healthcare Technologies A.S. Device including RF source of energy and vacuum system
US11883643B2 (en) 2016-05-03 2024-01-30 Btl Healthcare Technologies A.S. Systems and methods for treatment of a patient including RF and electrical energy
US10695575B1 (en) 2016-05-10 2020-06-30 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US11534619B2 (en) 2016-05-10 2022-12-27 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US11691024B2 (en) 2016-05-10 2023-07-04 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US11464994B2 (en) 2016-05-10 2022-10-11 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US11590356B2 (en) 2016-05-10 2023-02-28 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US10709895B2 (en) 2016-05-10 2020-07-14 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US11458307B2 (en) 2016-05-23 2022-10-04 Btl Healthcare Technologies A.S. Systems and methods for tissue treatment
US11185690B2 (en) 2016-05-23 2021-11-30 BTL Healthcare Technologies, a.s. Systems and methods for tissue treatment
US11896821B2 (en) 2016-05-23 2024-02-13 Btl Healthcare Technologies A.S. Systems and methods for tissue treatment
US11878162B2 (en) 2016-05-23 2024-01-23 Btl Healthcare Technologies A.S. Systems and methods for tissue treatment
US11623083B2 (en) 2016-05-23 2023-04-11 Btl Healthcare Technologies A.S. Systems and methods for tissue treatment
US11524171B2 (en) 2016-07-01 2022-12-13 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US11266852B2 (en) 2016-07-01 2022-03-08 Btl Healthcare Technologies A.S. Aesthetic method of biological structure treatment by magnetic field
US10632321B2 (en) 2016-07-01 2020-04-28 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US11607556B2 (en) 2016-07-01 2023-03-21 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US10596386B2 (en) 2016-07-01 2020-03-24 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US11484727B2 (en) 2016-07-01 2022-11-01 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US11628308B2 (en) 2016-07-01 2023-04-18 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US11497925B2 (en) 2016-07-01 2022-11-15 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US11794029B2 (en) 2016-07-01 2023-10-24 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US11679270B2 (en) 2016-07-01 2023-06-20 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US11247063B2 (en) 2019-04-11 2022-02-15 Btl Healthcare Technologies A.S. Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy
US11484725B2 (en) 2019-04-11 2022-11-01 Btl Medical Solutions A.S. Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy
US11679255B2 (en) 2020-05-04 2023-06-20 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient
US11806528B2 (en) 2020-05-04 2023-11-07 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient
US11813451B2 (en) 2020-05-04 2023-11-14 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient
US11826565B2 (en) 2020-05-04 2023-11-28 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient
US11633596B2 (en) 2020-05-04 2023-04-25 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient
US11878167B2 (en) 2020-05-04 2024-01-23 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient
US11491329B2 (en) 2020-05-04 2022-11-08 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient
US11896816B2 (en) 2021-11-03 2024-02-13 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient

Also Published As

Publication number Publication date
MX2012012158A (en) 2014-04-02

Similar Documents

Publication Publication Date Title
WO2013191699A1 (en) Cooling device for lipid-rich cell disruption
US11219549B2 (en) Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile
AU2011280986B2 (en) Methods and apparatus for therapeutic application of thermal energy
BRPI0708209A2 (en) cooling device to remove heat from lipid rich subcutaneous cells
US11944568B2 (en) Cooling system for localized and non-invasive cooling treatment
JP2008522791A (en) Method and apparatus comprising a coolant having a phase transition temperature for non-invasively removing heat from subcutaneous lipid-rich cells
CA2758240A1 (en) Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells
EP2268241A1 (en) Device and method to assist the body thermoregulation
US20160287431A1 (en) Systems and Methods for Transferring Heat with a Portion of a Mammal
WO2015175194A1 (en) Devices and methods for transferring heat with a portion of a mammal
CN218220421U (en) Heat-insulation bag

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: MX/A/2012/012158

Country of ref document: MX

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12879552

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205N DATED 27/02/2015)

122 Ep: pct application non-entry in european phase

Ref document number: 12879552

Country of ref document: EP

Kind code of ref document: A1